Effectiveness of mechanical circulatory support in children with acute fulminant and persistent myocarditis

Ivan Wilmot1, David L S Morales, Jack F Price

  • 1Lillie Frank Abercrombie Section of Cardiology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.

Insights

Mechanical circulatory support (MCS) offers a life-saving treatment for children with acute fulminant myocarditis. Survival rates are high, especially when viral infections are absent.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Cardiovascular Surgery

Background:

  • Acute fulminant myocarditis poses a significant threat to children's lives.
  • Mechanical circulatory support (MCS) shows promise in bridging pediatric patients to recovery or heart transplantation.

Purpose of the Study:

  • To evaluate the effectiveness of MCS in pediatric myocarditis cases.
  • To identify risk factors linked to adverse outcomes in children receiving MCS for myocarditis.

Main Methods:

  • Retrospective analysis of 16 children treated with MCS (extracorporeal membrane oxygenation, ventricular assist devices, or both) between 2001 and 2009.
  • Utilized polymerase chain reaction for viral pathogen detection and histologic analysis for myocardial inflammation assessment.

Main Results:

  • Overall survival rate was 75% (12/16), with 7 patients recovering ventricular function and 5 undergoing heart transplantation.
  • Significant improvement in left ventricular ejection fraction observed in patients bridged to recovery (20% to 62%, P = .0004).
  • Viral presence was associated with increased mortality or need for transplantation (P = .011); absence of viral infection and inflammation correlated with recovery (P values .011 and .044).

Conclusions:

  • MCS is a critical, life-saving intervention for children with acute fulminant and persistent myocarditis.
  • The absence of viral infection is a key factor associated with favorable outcomes in pediatric myocarditis patients treated with MCS.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...